摘要
目的探讨抗原125在维持性腹膜透析患者透析充分性评价中的应用价值。方法对2006年6月—2009年10月在我院肾病内科腹透中心行腹膜透析的52例终末期肾病患者的临床资料进行分析。结果 52例患者中高转运者6例,高平均转运者28例,低平均转运者16例,低转运者2例。以透出液内溶质与血浆中相应溶质比值(D/Per值)0.65为分界线,将52例患者分为A、B两组,A组抗原125水平为(11.2±3.4)U/ml,B组抗原125水平为(16.6±4.2)U/ml,两组比较差异有统计学意义(t=25.332,P<0.01)。结论抗原125对维持性腹透患者的透析充分性有很高的评价功能,值得推广应用。
Objective To evaluate and analyze the antigen 125 in maintenance peritoneal dialysis adequacy in peritoneal dialysis patients. Methods Clinical data of 52 terminal stage patients that underwent peritoneal dialysis in our hospital from June 2006 to October 2009 were analyzed. Results Of the 52 patients,6 patients had high transporter,28 had high-average transporter,16 had low-average transporter and 2 had low transporter.Taking D / Per value 0.65 as dividing line,52 patients were divided into group A and group B.The antigen 125 were(11.2±3.4)U/ml and(16.6±4.2)U/ml respectively in group A and group B,and the difference between the two groups was statistical(t=25.332,P0.01). Conclusion Antigen 125 has a high evaluation functio for maintenance peritoneal dialysis adequacy in peritoneal dialysis patients n,and it should be widely applied.
出处
《中国全科医学》
CAS
CSCD
北大核心
2011年第8期902-903,共2页
Chinese General Practice
关键词
腹膜透析
终末期肾病
透析充分性
评价
抗原125
Peritoneal dialysis
End-stage renal disease
Dialysis adequacy
Evaluation
Antigen 125